🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesGLP-1 and beta-cell preservation — 12 month update Page 2

GLP-1 and beta-cell preservation — 12 month update

PeptideSynthNJ Sun, Dec 28, 2025 at 4:58 AM 7 replies 1,011 viewsPage 2 of 2
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
Dec 28, 2025 at 7:48 AM#6

Saving this for reference. Quality thread.

24 15maya_sedona, stefan_berlin, Dr.EM_Chicago and 21 others
Reply Quote Save Share Report
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Dec 28, 2025 at 8:05 AM#7

Slightly tangential to GLP-1 and beta-cell but wendy_avl reminded me — has anyone else noticed changes in their alcohol tolerance?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

38 3mark_tokyo, hans_munich, jason_sac26 and 35 others
Reply Quote Save Share Report
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Dec 28, 2025 at 8:22 AM#8

+1 to wendy_avl. Especially the point about "A few questions about your GLP-1 and bet..." — I have seen the same in my own experience with GLP-1 and beta-cell.

Last edited: Dec 28, 2025 at 9:22 AM
15 19Dr.EndoEP, GraceAZ_72, carl_compliance and 12 others
Reply Quote Save Share Report
SkepticalSean
Member
98
345
Jan 2025
Maine
Dec 28, 2025 at 8:39 AM#9

Dr.LeslieOBGYN — that is really helpful context on GLP-1 and beta-cell. Follow-up question: what labs did your doctor order to monitor this?

I am in a similar situation (just started) and trying to set realistic expectations.

22 0tammy_FL, Dr.LipidDallas, alex_tucson and 19 others
Reply Quote Save Share Report
Dr.SportsMedIN
Senior Member
1,456
6,789
Feb 2024
Indianapolis, IN
Dec 28, 2025 at 8:56 AM#10

To answer Dr.ReproEndo's question specifically:

From a clinical standpoint, GLP-1 and beta-cell is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.

29 0rachel_ABQ, traveltech_sara, AttorneyGrant and 26 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register